ORAGENICS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | $37,653 | $131,521 | $86,987 |
| Operating income | -$9.4M | -$10.6M | -$20.9M | -$14.4M | -$15.8M |
| Operating expenses | $9.4M | $10.6M | $20.9M | $14.6M | $15.9M |
| Cash from operations | -$9.2M | -$8.6M | -$7.3M | -$15.2M | -$13.5M |
| Capital expenditure | — | — | — | $127,519 | $43,876 |
| Free cash flow | — | — | — | -$15.4M | -$13.5M |
| Total assets | $10.1M | $1.5M | $5.0M | $14.8M | $28.2M |
| Total liabilities | $1.8M | $1.7M | $1.8M | — | — |
Shares outstanding 4.5M · Free float 82.0%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.